Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New phenylthiosemicarbazide-phenoxy-1,2,3-triazole-N-phenylacetamides as dual inhibitors against α-glucosidase and PTP-1B for the treatment of type 2 diabetes.
Ansariashlaghi S, Fakhrioliaei A, Mohammadi-Khanaposhtani M, Noori M, Asadi M, Mojtabavi S, Faramarzi MA, Esfahani EN, Rastegar H, Larijani B, Azizian H, Mahdavi M. Ansariashlaghi S, et al. Among authors: azizian h. Arch Pharm (Weinheim). 2024 Apr 9:e2300517. doi: 10.1002/ardp.202300517. Online ahead of print. Arch Pharm (Weinheim). 2024. PMID: 38593290
Aryl-quinoline-4-carbonyl hydrazone bearing different 2-methoxyphenoxyacetamides as potent α-glucosidase inhibitors; molecular dynamics, kinetic and structure-activity relationship studies.
Hamedifar H, Mirfattahi M, Khalili Ghomi M, Azizian H, Iraji A, Noori M, Moazzam A, Dastyafteh N, Nokhbehzaim A, Mehrpour K, Javanshir S, Mojtabavi S, Faramarzi MA, Larijani B, Hajimiri MH, Mahdavi M. Hamedifar H, et al. Among authors: azizian h. Sci Rep. 2024 Jan 3;14(1):388. doi: 10.1038/s41598-023-50395-8. Sci Rep. 2024. PMID: 38172167 Free PMC article.
The G-Protein-Coupled Estrogen Receptor Agonist Prevents Cardiac Lipid Accumulation by Stimulating Cardiac Peroxisome Proliferator-Activated Receptor α: A Preclinical Study in Ovariectomized-Diabetic Rat Model.
Jafarynezhad F, Shahbazian M, Farhadi Z, Yadeghari M, Rezvani ME, Safari F, Azizian H. Jafarynezhad F, et al. Among authors: azizian h. Int J Endocrinol Metab. 2022 Jul 12;20(3):e123560. doi: 10.5812/ijem-123560. eCollection 2022 Jul. Int J Endocrinol Metab. 2022. PMID: 36407026 Free PMC article.
Docking study, molecular dynamic, synthesis, anti-α-glucosidase assessment, and ADMET prediction of new benzimidazole-Schiff base derivatives.
Azizian H, Pedrood K, Moazzam A, Valizadeh Y, Khavaninzadeh K, Zamani A, Mohammadi-Khanaposhtani M, Mojtabavi S, Faramarzi MA, Hosseini S, Sarrafi Y, Adibi H, Larijani B, Rastegar H, Mahdavi M. Azizian H, et al. Sci Rep. 2022 Sep 1;12(1):14870. doi: 10.1038/s41598-022-18896-0. Sci Rep. 2022. PMID: 36050498 Free PMC article.
Design and synthesis of new N-thioacylated ciprofloxacin derivatives as urease inhibitors with potential antibacterial activity.
Pedrood K, Azizian H, Montazer MN, Moazzam A, Asadi M, Montazeri H, Biglar M, Zamani M, Larijani B, Zomorodian K, Mohammadi-Khanaposhtani M, Irajie C, Amanlou M, Iraji A, Mahdavi M. Pedrood K, et al. Among authors: azizian h. Sci Rep. 2022 Aug 15;12(1):13827. doi: 10.1038/s41598-022-17993-4. Sci Rep. 2022. PMID: 35970866 Free PMC article.
Design, synthesis, in vitro α-glucosidase inhibition, docking, and molecular dynamics of new phthalimide-benzenesulfonamide hybrids for targeting type 2 diabetes.
Askarzadeh M, Azizian H, Adib M, Mohammadi-Khanaposhtani M, Mojtabavi S, Faramarzi MA, Sajjadi-Jazi SM, Larijani B, Hamedifar H, Mahdavi M. Askarzadeh M, et al. Among authors: azizian h. Sci Rep. 2022 Jun 22;12(1):10569. doi: 10.1038/s41598-022-14896-2. Sci Rep. 2022. PMID: 35732907 Free PMC article.
60 results